IHAM
TMO icon

Integral Health Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Integral Health Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,000
Closed -$9.83M – 115
2026
Q1 		$9.83M Buy
+20,000
New +$10.9M 0.47% 57
2024
Q3 		– Sell
-25,000
Closed -$13.8M – 99
2024
Q2 		$13.8M Buy
+25,000
New +$14.3M 1.31% 24

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Integral Health Asset Management's TMO Position: Q2 2026 in Review

Integral Health Asset Management sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 20,000 shares — an estimated $9.83M sold.

Integral Health Asset Management first reported a position in TMO in Q2 2024 and held it in 2 quarters. The position peaked at $13.8M in Q2 2024. 2,624 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Integral Health Asset Management reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Integral Health Asset Management sold 20,000 Thermo Fisher Scientific shares in Q2 2026, an estimated $9.83M.
  • Integral Health Asset Management first reported a position in Thermo Fisher Scientific in Q2 2024 and held it in 2 quarters.
  • Integral Health Asset Management's Thermo Fisher Scientific position peaked at $13.8M in Q2 2024.
  • 2,624 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.